TSS:Rfhg 79916.1

Basic information about the TSS

---

TSS ID: rfhg_79916.1 Species: human Chr: chr6		Start: 28921915 End: 28922118 Strand: -
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000498117.1:0 GeneID: 5987 HGNC/MGI_ID: HGNC:9975 UniProt_ID: Nearer transcript ids and distances:

Gene_name: TRIM27 Gene_symbol: TRIM27 Gene_synonyms: RNF76 Gene_source: HGNC:9975

TATA-Box annotation

---

Distance to TSS:	1969
Nearest PromoterID:	NM_006510
Entrez ID:	5987
Nearest Unigene:	Hs.440382
Nearest Refseq:	NM_006510
Nearest Ensembl:	ENSG00000204713
Gene Name:	TRIM27
Gene Alias:	RFP|RNF76
Gene Type:	protein-coding
CpG%:	0.019704
GC%:	0.475490
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):	154(CCATTTAAAAAG,-,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TRIM27 p2@TRIM27 p3@TRIM27 p4@TRIM27 p5@TRIM27
Sample		p1@TRIM27	p2@TRIM27	p3@TRIM27	p4@TRIM27	p5@TRIM27
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	87.27	3.90	1.36	1.75	4.68
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	94.89	4.05	2.02	2.02	3.24
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	92.40	4.82	1.35	1.16	2.70
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	96.05	6.24	2.08	1.87	2.49
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	101.46	6.07	3.60	1.35	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	92.64	4.46	1.55	1.36	3.10
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	92.60	6.97	4.14	1.74	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	75.81	7.02	1.21	1.45	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	88.05	5.98	2.78	0.64	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	92.16	12.75	4.64	2.32	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	99.04	8.89	4.04	1.62	4.04
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	76.03	9.35	6.50	0.81	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.44	2.26	3.71	0.32	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	24.81	1.65	2.71	0.90	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	24.37	1.76	3.95	0.00	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	28.42	1.51	3.27	0.25	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	20.09	1.31	2.40	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	29.11	1.69	1.69	1.69	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	24.53	2.13	2.67	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	26.33	1.65	2.86	0.60	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	25.93	2.14	4.14	0.53	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	29.52	2.24	3.11	0.35	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	24.69	2.46	2.97	0.52	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	27.66	2.43	2.18	1.21	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	29.67	1.81	2.06	0.52	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	26.27	2.85	3.17	0.32	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.82	2.20	3.30	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	22.63	1.89	3.06	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	24.39	1.94	2.91	0.65	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	22.62	1.63	2.53	0.54	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	25.54	2.93	2.51	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	24.42	1.56	1.76	0.00	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	23.00	1.69	2.11	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.00	2.31	1.15	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	17.39	1.12	3.18	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	20.50	1.34	2.87	0.77	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	21.87	1.23	1.23	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	18.94	1.01	3.02	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	23.77	1.62	2.43	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	19.20	2.64	2.16	1.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	22.35	2.35	1.65	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.64	3.37	1.46	1.02	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	26.57	2.74	2.53	0.63	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	30.77	3.67	3.50	0.70	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	21.08	4.62	2.21	1.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.62	3.26	3.26	0.93	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	31.67	4.08	5.52	1.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	31.30	4.47	5.36	1.49	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	32.79	8.38	4.55	0.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	33.77	10.31	3.44	1.42	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	26.64	6.97	4.10	1.02	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.47	11.34	7.12	2.89	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	34.07	11.71	4.26	2.13	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	36.45	6.96	2.32	0.99	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.10	5.03	4.19	0.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	18.37	10.56	2.30	0.46	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	33.38	9.72	2.59	0.97	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	35.65	8.67	3.21	0.96	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	22.95	8.17	2.51	2.51	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	40.89	7.76	5.64	0.00	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	36.45	8.41	2.24	1.12	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	5.57	1.59	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	30.24	4.08	2.38	0.68	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	35.42	5.52	2.92	1.30	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	41.18	6.39	2.84	0.71	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	35.10	4.39	3.41	0.49	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	30.25	7.44	1.49	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	35.18	4.22	3.28	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.85	5.63	1.99	1.32	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	33.41	2.47	2.78	0.31	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	33.94	4.89	2.45	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	31.04	3.17	3.17	1.58	0.32
Adipocyte - breast, donor2	11327-117E4	25.99	3.21	1.93	0.96	0.64
Adipocyte - omental, donor1	11473-119C6	31.17	2.80	2.93	0.13	1.27
Adipocyte - omental, donor2	11474-119C7	28.40	1.49	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	20.10	1.34	3.01	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	24.24	0.64	0.00	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	26.39	4.40	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	23.48	4.52	2.26	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	26.94	1.39	2.95	0.52	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	29.14	4.11	1.76	0.39	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	25.74	3.35	2.32	0.77	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	18.40	2.51	3.90	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	23.51	2.35	2.94	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	20.03	1.37	2.82	0.56	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	19.69	2.58	1.61	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	14.40	0.00	3.20	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	21.14	1.11	3.90	3.90	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	15.80	2.91	2.50	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	16.83	2.51	4.27	1.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	16.69	0.98	1.96	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	10.05	1.22	2.13	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	48.40	5.30	2.21	1.77	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	58.81	6.10	3.23	3.94	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	22.76	5.99	1.20	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	31.48	1.98	2.34	0.72	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	36.82	0.00	8.37	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	36.57	1.85	2.67	0.21	1.85
Anulus Pulposus Cell, donor1	11248-116E6	17.85	1.72	5.38	0.57	1.03
Anulus Pulposus Cell, donor2	11463-119B5	19.35	0.49	3.67	0.73	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.48	2.25	3.59	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	25.61	3.91	3.04	3.04	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	23.54	0.00	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.65	0.90	3.29	0.90	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	21.50	2.53	3.79	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.86	3.30	3.30	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	16.57	2.60	2.27	1.62	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	22.82	2.43	1.46	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	14.25	1.78	2.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	22.97	1.51	3.77	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	18.87	2.90	5.08	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	1.25	5.02	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	29.32	4.12	4.45	0.99	1.32
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	23.20	4.09	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	23.07	3.32	3.32	0.90	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	22.50	3.21	5.89	0.00	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	21.35	2.27	2.46	0.76	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	24.06	4.28	3.21	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	15.61	2.93	1.95	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.24	2.65	3.32	0.66	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	2.40	6.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	18.53	2.74	3.95	1.03	1.37
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	20.39	3.40	4.85	1.46	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	25.80	1.90	2.28	0.00	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	19.38	4.85	6.06	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.82	3.42	3.42	1.71	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.31	2.78	4.28	1.07	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.52	3.87	4.39	1.03	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	19.71	2.35	4.22	1.41	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	19.61	3.22	2.25	0.32	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.26	4.28	3.57	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.79	1.17	3.51	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.97	1.81	2.71	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	7.13	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	21.36	3.05	4.58	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	17.32	3.31	2.55	0.25	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.70	1.91	3.18	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.15	3.02	2.16	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	19.05	2.75	2.96	0.64	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	23.49	4.35	2.32	0.29	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	20.78	0.00	4.72	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	23.22	3.22	2.54	1.36	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	18.44	2.79	2.79	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	25.27	7.82	1.20	1.80	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	24.79	0.73	3.64	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	19.31	1.38	3.91	1.38	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.88	4.58	4.32	0.76	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	25.19	2.48	3.72	1.24	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	23.26	3.06	3.37	0.61	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.51	2.87	3.35	1.91	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	22.17	3.10	4.66	0.22	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	27.46	1.53	3.05	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.28	2.22	3.32	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	23.30	3.71	2.91	0.53	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	28.35	3.27	5.45	1.45	0.36
Astrocyte - cerebellum, donor1	11500-119F6	57.36	3.81	4.05	3.81	2.09
Astrocyte - cerebellum, donor2	11580-120F5	48.44	4.62	4.11	2.05	1.54
Astrocyte - cerebellum, donor3	11661-122F5	50.55	2.10	4.40	0.63	1.89
Astrocyte - cerebral cortex, donor1	11235-116D2	42.88	2.09	3.49	1.39	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	50.31	2.91	3.40	1.78	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	53.10	2.24	2.83	1.04	1.79
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	61.01	3.90	3.67	1.72	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	70.91	6.01	2.26	3.38	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	61.34	3.98	2.28	2.28	1.93
Basophils, donor1	12241-129G9	7.58	2.88	3.92	0.26	0.26
Basophils, donor2	12242-129H1	9.74	1.08	3.97	1.80	1.44
Basophils, donor3	12243-129H2	12.35	5.73	3.23	0.44	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	22.21	0.86	1.94	0.00	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	37.49	4.11	0.46	1.37	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	7.17	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	30.75	2.51	5.02	1.88	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	30.98	3.74	3.74	1.46	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	33.85	3.91	3.68	0.69	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	23.21	0.72	3.60	0.72	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	73.79	6.80	3.40	3.50	2.27
Burkitt's lymphoma cell line:RAJI	10476-106I8	65.91	6.99	2.56	3.73	1.86
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	74.19	9.27	5.76	2.56	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	10.14	4.51	3.38	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	8.17	1.86	2.41	0.00	0.37
CD14+ Monocytes, donor3	11381-118B4	12.29	2.85	2.20	0.22	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	36.23	1.70	14.44	1.42	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	35.25	2.65	6.07	1.14	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	33.53	2.30	12.16	0.33	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	39.61	3.04	6.79	1.45	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	22.63	1.21	4.22	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	43.59	3.79	9.48	1.42	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	20.59	1.17	3.68	0.84	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	13.52	2.21	1.38	1.10	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	25.54	1.98	3.22	0.50	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	14.69	1.96	4.31	0.39	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	18.34	1.78	2.67	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	25.25	3.26	2.83	1.09	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	8.66	2.11	2.11	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	15.84	2.64	1.06	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	23.30	2.22	3.33	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	19.19	3.12	5.06	0.74	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	20.15	0.80	3.99	0.60	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	18.32	1.67	7.70	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	11.67	2.06	2.75	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	9.50	1.36	1.13	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	8.73	0.87	2.18	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	37.12	4.84	6.72	1.88	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	31.05	3.66	5.41	1.05	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	48.39	5.47	12.20	2.52	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	12.68	1.47	2.39	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	14.44	0.35	1.41	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	22.37	2.63	3.95	0.44	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	21.80	2.09	2.44	1.74	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	15.61	1.86	0.74	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	25.87	2.80	3.45	1.08	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	15.97	2.05	1.64	0.41	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	10.43	0.93	1.16	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	12.53	2.55	2.09	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	24.85	5.01	4.80	2.40	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	31.42	6.01	4.85	1.62	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	34.44	6.50	5.20	1.52	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	50.61	5.92	7.94	1.87	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	42.09	4.19	8.73	1.75	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	31.44	3.12	6.91	2.01	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	46.44	8.68	7.14	2.81	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	39.52	7.03	8.34	3.29	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	42.53	7.79	7.79	2.53	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	63.00	4.06	14.23	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	55.59	2.71	14.92	6.10	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	54.89	4.14	10.36	3.11	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	70.36	5.33	13.33	4.26	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	57.90	3.75	14.47	3.75	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	55.45	5.62	9.83	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	63.53	4.71	17.26	6.27	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	59.32	6.59	19.77	2.64	1.32
CD19+ B Cells, donor1	11544-120B5	33.70	1.64	2.47	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	16.68	0.00	2.90	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	25.24	0.00	2.52	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	24.65	1.62	8.89	0.81	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	28.36	0.40	2.80	0.40	0.80
CD34+ Progenitors, donor1	11545-120B6	16.06	1.00	1.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	6.74	2.81	2.81	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	78.16	6.76	5.64	1.50	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	78.69	9.70	3.61	2.25	2.48
CD4+ T Cells, donor1	11225-116C1	18.92	2.14	2.50	1.07	0.36
CD4+ T Cells, donor2	11306-117C1	14.70	1.84	3.67	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	21.65	2.74	2.13	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	60.24	3.06	9.70	4.59	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	72.77	2.25	11.01	1.35	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	89.11	3.16	5.46	4.31	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	53.10	0.47	11.85	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	67.42	4.21	9.83	1.40	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	75.81	0.00	13.18	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	40.90	3.18	7.51	1.88	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	49.99	3.22	10.17	1.53	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	47.72	1.77	3.39	2.58	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	34.97	1.79	9.41	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	40.53	3.84	11.53	2.10	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	36.52	1.76	2.64	0.88	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	45.96	5.48	7.17	3.37	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	63.16	7.27	11.22	2.91	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	72.84	7.02	4.34	3.68	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	60.91	0.54	11.42	2.45	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	66.99	2.14	10.72	1.61	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	57.38	1.79	5.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	49.51	4.26	4.26	2.78	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	51.77	4.33	8.23	2.82	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	54.64	4.83	5.04	1.26	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	40.45	1.52	8.09	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	36.83	1.73	10.83	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	31.38	1.74	4.36	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	91.06	2.97	17.82	1.48	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	89.55	5.54	23.08	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	86.54	1.40	20.94	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	53.17	1.11	12.46	3.88	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	63.80	3.19	15.46	0.98	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	75.46	10.78	21.56	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	64.46	3.22	20.05	2.51	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	70.63	2.77	18.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	13.42	2.62	5.57	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	12.01	1.50	1.50	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	20.96	2.02	3.03	0.76	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	61.25	13.08	2.75	2.52	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	50.32	12.46	0.72	3.59	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	57.73	13.13	2.46	2.19	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	51.64	9.61	3.00	3.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	62.40	10.80	2.64	3.12	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	50.48	8.64	0.91	2.50	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	49.32	8.47	1.52	2.17	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	56.85	3.95	0.79	2.11	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	52.53	6.33	1.88	1.64	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	51.62	7.85	2.11	3.32	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	47.35	12.49	1.16	2.61	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	49.02	8.79	2.40	2.13	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	25.39	1.75	1.75	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	21.86	2.73	0.46	1.82	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	26.11	1.49	1.49	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	64.11	9.00	1.80	1.80	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	63.01	10.07	3.16	1.73	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	61.75	11.78	1.41	2.12	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	54.51	6.97	1.90	3.49	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	54.44	6.15	1.85	1.54	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	52.58	5.45	1.60	2.24	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	47.81	6.12	0.76	1.91	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	50.45	9.46	0.00	2.36	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	52.95	8.32	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	36.94	5.62	4.82	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	54.56	8.39	3.50	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	38.07	2.00	1.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	12.79	0.00	0.00	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	33.10	2.96	2.47	0.99	0.99
Cardiac Myocyte, donor3	11686-122I3	21.68	3.16	1.58	0.74	0.42
Chondrocyte - de diff, donor1	11261-116G1	26.35	2.43	1.39	1.04	0.35
Chondrocyte - de diff, donor2	11338-117F6	26.65	2.84	2.84	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	27.42	3.64	1.37	1.14	1.25
Chondrocyte - re diff, donor2	11339-117F7	46.55	3.58	4.48	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	34.78	2.83	3.64	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	36.15	2.64	3.79	1.15	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	43.39	2.57	3.42	2.78	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	42.48	4.16	3.36	1.50	1.50
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	33.29	5.04	3.48	1.28	0.83
Corneal Epithelial Cells, donor1	11526-119I5	31.84	2.20	5.05	0.66	1.10
Corneal Epithelial Cells, donor2	11606-120I4	14.79	1.14	0.00	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	23.52	2.30	2.56	0.77	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	35.00	1.32	2.81	1.32	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	36.59	0.95	3.47	0.95	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	0.00	6.90	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	37.15	1.94	5.40	0.65	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	23.91	2.05	2.05	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	23.50	3.92	5.22	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	16.45	1.45	4.84	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	29.68	6.84	3.67	3.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	22.88	2.93	2.35	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	31.67	6.22	1.98	2.26	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	29.88	7.08	1.18	1.57	0.79
Endothelial Cells - Artery, donor1	11264-116G4	22.11	5.82	4.07	1.75	0.29
Endothelial Cells - Artery, donor2	11341-117F9	43.29	11.29	3.29	2.59	0.47
Endothelial Cells - Artery, donor3	11413-118E9	35.94	6.14	3.68	4.03	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	33.91	5.98	3.32	1.99	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.17	5.17	3.35	2.13	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.91	2.54	2.54	1.97	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	23.47	2.08	3.57	1.78	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	27.07	9.37	2.08	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	31.90	4.11	2.41	0.71	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	32.01	5.60	3.60	5.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	36.69	8.39	4.72	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	45.23	8.45	2.98	2.61	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	21.73	4.78	2.39	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	28.70	5.50	2.93	0.85	0.12
Endothelial Cells - Vein, donor1	11267-116G7	36.40	14.79	3.41	3.41	0.00
Endothelial Cells - Vein, donor2	11344-117G3	40.51	9.78	2.79	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	49.61	10.05	3.93	2.83	0.31
Eosinophils, donor1	12244-129H3	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	24.75	1.65	3.30	1.65	0.00
Eosinophils, donor3	12246-129H5	7.13	0.00	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	21.50	1.22	2.20	0.24	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	0.00	2.08	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.55	3.28	2.05	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.44	2.30	2.08	0.44	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.95	4.01	2.28	0.98	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	31.53	4.12	3.88	2.06	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	40.80	6.41	5.32	2.32	1.36
Fibroblast - Aortic Adventitial, donor2	11326-117E3	25.63	2.74	2.11	1.05	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	42.69	5.27	1.32	1.05	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.57	5.98	2.33	0.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	29.03	2.27	0.91	3.63	1.36
Fibroblast - Cardiac, donor2	11345-117G4	49.27	7.58	1.52	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	30.75	5.99	3.00	1.42	1.10
Fibroblast - Cardiac, donor4	11452-119A3	34.55	4.85	4.24	0.91	0.91
Fibroblast - Cardiac, donor5	11456-119A7	32.36	2.16	2.16	0.63	0.25
Fibroblast - Cardiac, donor6	11460-119B2	39.41	3.18	2.73	1.36	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	36.31	1.74	3.89	1.47	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	29.34	3.02	3.02	0.43	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	2.93	1.46	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	43.59	3.00	5.07	0.69	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	30.70	2.54	4.41	0.68	0.68
Fibroblast - Dermal, donor1	11269-116G9	26.06	2.11	3.76	0.47	0.70
Fibroblast - Dermal, donor2	11346-117G5	37.26	3.30	5.19	1.42	0.47
Fibroblast - Dermal, donor3	11418-118F5	30.22	4.71	3.87	0.85	1.09
Fibroblast - Dermal, donor4	11450-119A1	31.65	1.70	2.60	0.68	1.58
Fibroblast - Dermal, donor5	11454-119A5	41.00	1.57	2.27	0.87	0.87
Fibroblast - Dermal, donor6	11458-119A9	43.85	2.27	2.92	0.65	1.95
Fibroblast - Gingival, donor1	11237-116D4	23.53	0.83	4.37	0.83	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	28.82	1.83	3.67	1.05	0.52
Fibroblast - Gingival, donor2	11318-117D4	42.57	2.77	1.71	1.71	0.92
Fibroblast - Gingival, donor3	11394-118C8	26.40	1.16	3.00	0.19	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	33.24	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	26.43	1.94	1.59	1.06	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	32.43	3.74	2.49	1.09	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	27.18	1.76	2.03	0.68	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	26.82	2.47	1.76	0.35	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	27.93	4.39	2.63	0.58	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	21.13	2.73	2.32	1.23	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	25.56	2.63	1.86	0.99	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	32.14	1.32	2.93	0.73	0.73
Fibroblast - Lung, donor1	11270-116H1	20.39	2.72	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	34.32	4.48	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	42.21	2.74	3.38	0.84	1.48
Fibroblast - Lymphatic, donor1	11506-119G3	47.48	2.50	2.50	3.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	33.57	2.80	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	29.39	2.52	3.92	0.00	0.56
Fibroblast - Mammary, donor1	11540-120B1	46.69	4.47	4.87	1.22	1.62
Fibroblast - Mammary, donor2	11620-122A9	43.94	11.98	11.98	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	37.82	2.33	4.07	1.55	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	41.26	2.73	2.28	1.37	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	27.54	3.37	2.45	0.61	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.10	1.53	1.14	1.14	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	28.62	2.16	2.70	0.27	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	24.01	1.86	1.86	0.81	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	34.15	4.86	2.43	1.33	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	44.70	5.08	3.05	1.02	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	41.43	6.01	5.35	0.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	24.51	2.77	3.95	0.40	2.37
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	46.04	3.77	1.59	2.58	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	25.75	1.07	1.60	0.36	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	25.42	1.97	2.76	0.99	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	45.13	3.61	1.81	0.60	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	25.58	1.94	1.51	0.76	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	39.99	1.52	1.52	1.52	1.27
Fibroblast - skin normal, donor1	11553-120C5	21.49	2.30	2.46	0.33	1.15
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	37.09	4.01	2.41	2.81	0.60
Fibroblast - skin normal, donor2	11561-120D4	21.50	1.71	2.61	0.60	1.41
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	53.80	2.72	1.81	2.12	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	31.32	2.15	2.24	0.41	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	29.23	1.37	1.71	1.54	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	30.22	2.63	2.63	1.64	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	22.69	1.49	1.92	0.85	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	31.04	2.87	1.01	0.51	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.49	1.25	1.25	0.78	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.07	0.00	2.61	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	34.32	2.95	5.03	1.39	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	32.01	5.73	4.94	1.04	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	24.27	1.53	2.81	0.51	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	88.80	7.66	3.06	2.30	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	95.71	9.57	8.29	4.47	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	76.17	2.57	3.71	0.86	4.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	81.07	4.41	5.52	0.28	4.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	63.02	2.51	2.51	2.51	3.20
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	78.66	3.17	1.59	0.79	4.56
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	77.98	2.11	5.82	0.79	4.49
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	64.25	4.89	3.26	0.98	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	57.05	0.88	4.42	1.33	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	54.83	2.12	4.10	0.85	2.69
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	46.79	2.71	2.22	0.25	2.09
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	59.10	3.49	3.22	1.88	2.95
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	52.04	2.23	3.10	0.74	2.48
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	45.68	1.80	1.94	0.42	3.46
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	43.51	2.44	1.22	1.83	2.03
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	46.09	2.51	2.74	1.14	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	46.46	1.74	2.62	1.00	1.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	43.93	1.97	2.62	0.66	2.84
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	52.30	3.55	3.84	1.48	2.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	49.75	1.43	3.97	0.64	1.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	42.23	3.35	2.68	0.89	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	54.64	2.22	1.21	1.01	2.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	46.31	2.54	2.54	0.85	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	50.99	4.79	3.99	2.04	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	51.92	1.46	2.81	0.94	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.28	1.71	1.88	0.68	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	41.61	2.43	2.77	1.00	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	50.67	5.41	3.91	2.25	1.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.12	5.72	4.29	1.84	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	46.42	2.89	3.71	1.44	2.68
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	49.23	1.96	2.54	0.23	2.19
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	50.53	2.50	2.67	1.17	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	38.13	1.32	1.98	0.22	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	54.98	2.58	3.44	0.61	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	46.68	3.57	2.76	1.46	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	43.30	1.60	2.57	0.96	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	37.14	1.52	2.46	0.19	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	37.01	2.85	2.37	0.95	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	39.23	2.43	2.43	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	40.67	2.93	2.51	0.63	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	34.03	2.20	2.63	0.66	1.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	37.31	2.81	5.05	0.56	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	33.89	4.07	2.59	0.83	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	32.36	4.55	2.67	1.87	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	42.54	5.36	3.37	1.53	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	36.01	3.11	4.02	1.04	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	32.53	3.80	1.63	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	39.64	3.50	2.58	1.47	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	37.72	3.73	3.51	0.88	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	31.74	2.98	1.98	0.99	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	36.80	4.22	4.22	0.40	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	38.74	3.63	3.43	0.40	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	31.77	2.03	4.83	0.00	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	44.19	0.60	2.79	1.59	1.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	57.93	0.77	3.85	0.77	3.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	65.88	2.25	2.66	0.20	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	88.87	5.01	3.44	1.56	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	87.87	5.37	4.52	2.54	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	61.80	1.38	5.53	1.38	3.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	89.09	4.95	0.00	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	93.99	5.03	3.87	1.16	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	77.01	1.60	4.81	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	71.29	3.48	6.96	0.00	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	64.44	5.21	2.60	0.98	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	72.07	5.35	4.12	3.71	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	79.97	0.00	0.00	0.00	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	58.45	3.08	2.80	1.40	3.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	65.04	5.56	2.29	2.29	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	82.21	2.52	0.00	0.84	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	69.02	7.32	2.86	1.91	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	60.46	3.06	3.40	1.36	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	83.53	8.35	0.00	0.00	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	66.43	2.86	1.15	0.57	5.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	51.80	3.85	4.44	0.89	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	52.52	8.47	0.00	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	58.40	7.04	3.31	1.66	3.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	68.58	3.91	4.37	2.99	2.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	5.27	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	59.58	4.61	4.23	2.69	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	50.20	5.22	3.91	1.96	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	49.49	5.35	5.35	0.67	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	81.68	3.47	1.93	2.70	2.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	86.95	15.75	7.19	4.11	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	0.00	2.48	0.00	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	70.78	4.72	1.42	0.94	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	65.18	4.83	4.83	1.81	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	52.39	3.56	2.54	1.53	3.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	59.03	5.98	2.39	1.99	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	48.35	4.44	2.47	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	79.09	7.08	3.54	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	63.60	5.25	2.33	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	68.47	6.14	4.83	1.76	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	60.19	4.24	6.78	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	48.35	8.36	5.97	2.98	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	41.73	5.34	3.40	0.97	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	4.57	2.28	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	37.42	3.33	1.25	0.42	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	41.60	9.00	2.25	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	22.52	1.27	3.17	0.32	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	13.79	0.84	2.51	0.42	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	71.13	6.27	5.11	3.02	1.39
Hep-2 cells mock treated, biol_rep2	11899-125E9	74.61	8.78	6.08	1.01	2.36
Hep-2 cells mock treated, biol_rep3	11900-125F1	60.52	6.60	5.23	2.73	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	73.24	6.67	5.36	2.84	1.53
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	73.29	6.02	4.08	1.72	2.36
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	62.22	6.24	6.03	2.37	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	53.55	5.60	4.61	1.37	2.24
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	46.32	4.29	2.92	1.72	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	47.42	5.77	3.20	0.96	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	41.41	6.16	5.04	5.04	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	39.82	8.66	2.60	1.73	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	10.58	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	45.50	6.35	5.29	0.71	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	50.13	5.81	4.36	0.73	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	29.20	4.72	2.10	1.75	0.52
Hepatocyte, donor1	11523-119I2	32.69	29.05	4.84	6.05	0.00
Hepatocyte, donor2	11603-120I1	60.33	21.55	4.31	2.15	1.08
Hepatocyte, donor3	11684-122I1	31.29	20.86	4.91	3.07	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	91.38	5.22	4.57	0.00	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	36.70	9.26	3.15	2.10	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	21.82	3.70	2.33	0.41	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	175.11	19.10	22.29	0.00	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	133.51	13.35	26.70	6.68	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	216.67	27.08	54.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	184.12	13.84	12.46	2.77	6.92
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	132.64	10.01	10.01	7.51	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	11.87	35.60	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	212.72	17.94	12.81	0.00	17.94
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	137.12	22.85	13.71	0.00	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	211.16	32.49	12.99	0.00	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	128.38	11.67	11.67	3.33	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	130.70	10.89	25.41	3.63	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	194.55	22.50	13.23	9.26	9.26
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	130.82	11.09	6.65	5.54	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	188.58	15.71	10.48	5.24	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	117.15	13.86	11.34	1.26	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	163.94	10.83	6.19	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	190.25	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	147.94	10.34	7.75	1.29	3.23
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	164.21	14.49	9.66	8.05	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	155.33	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	164.61	17.93	11.41	2.44	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	157.85	14.69	12.17	4.62	4.20
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	201.21	28.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	156.72	15.27	6.43	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	95.10	8.31	7.39	5.54	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	241.29	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	102.43	13.22	8.97	1.89	2.36
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	117.91	8.16	10.88	4.53	5.44
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	117.94	29.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	139.90	15.07	9.69	4.30	5.38
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	149.91	15.25	7.62	2.54	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	180.73	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	156.23	11.48	9.57	5.10	3.83
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	136.70	14.58	5.47	7.29	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	110.63	31.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	145.67	12.14	9.28	5.00	4.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	179.19	0.00	9.95	3.32	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	125.09	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	110.81	9.26	7.41	2.47	2.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	142.24	15.80	14.05	7.02	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	157.16	15.72	6.29	3.14	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	162.72	4.87	6.26	2.09	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	137.21	6.64	15.49	4.43	8.85
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	139.41	16.21	12.97	6.48	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	149.10	5.23	9.59	2.62	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	114.74	2.25	9.00	0.00	9.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	108.02	3.48	6.97	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	145.08	8.53	10.67	1.07	5.33
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	142.70	9.70	13.85	1.39	8.31
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	151.03	11.40	5.70	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	146.35	8.28	11.97	1.84	4.60
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	102.86	6.05	12.10	0.00	9.08
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	161.43	6.21	12.42	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	133.23	6.34	8.46	2.11	8.46
Keratinocyte - epidermal, donor1	11272-116H3	29.62	1.96	2.86	1.31	0.73
Keratinocyte - epidermal, donor2	11349-117G8	37.48	5.27	3.51	0.59	1.17
Keratinocyte - epidermal, donor3	11421-118F8	33.32	4.45	3.41	1.04	0.47
Keratinocyte - oral, donor1	11251-116E9	29.06	1.82	4.09	0.11	1.48
Keratocytes, donor1	11527-119I6	46.07	4.47	3.09	1.03	0.00
Keratocytes, donor2	11607-120I5	65.62	10.55	4.69	7.03	3.52
Keratocytes, donor3	11688-122I5	25.69	2.37	0.99	0.79	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	8.79	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	24.81	2.16	3.24	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	27.68	1.96	3.81	0.58	1.50
Lens Epithelial Cells, donor3	11690-122I7	26.14	2.72	2.93	0.91	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	30.24	3.79	2.25	0.95	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	21.77	3.35	1.40	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	34.63	2.83	2.05	3.15	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	25.81	3.23	1.61	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	23.95	4.41	3.15	2.21	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	28.68	5.18	2.59	2.05	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	25.03	2.46	0.00	0.82	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	23.51	3.79	1.01	1.01	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	28.57	6.05	2.82	2.11	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	19.78	4.75	2.37	1.58	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	21.71	3.49	1.55	1.74	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	25.37	4.44	2.41	3.15	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	16.38	4.88	0.70	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	19.80	3.10	1.19	1.19	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	25.82	4.81	1.51	2.47	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.79	2.77	0.92	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.59	4.68	2.18	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	27.81	6.04	3.11	1.65	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	26.00	1.65	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	22.84	3.81	0.88	1.46	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	25.89	3.24	2.74	2.24	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.40	4.36	0.97	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	22.89	1.89	1.89	1.62	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	22.56	4.54	1.36	1.82	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	25.40	4.67	1.04	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	20.52	2.93	2.30	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.01	4.21	1.95	2.71	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	30.95	2.06	1.38	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	20.51	2.45	1.88	1.13	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	30.64	5.20	2.76	1.17	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	33.44	3.88	0.48	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	25.14	2.32	2.32	1.32	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	33.33	4.46	1.86	1.73	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	31.47	4.07	0.74	2.59	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	21.00	4.20	0.99	1.24	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	25.16	5.22	1.79	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	25.41	2.25	2.57	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	27.69	5.17	1.83	1.22	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	34.29	4.76	2.52	3.08	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	31.29	2.84	0.00	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	25.69	3.88	1.45	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	36.26	5.14	0.62	1.40	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	31.16	4.66	1.79	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	21.56	2.61	1.96	1.96	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	31.55	5.89	1.65	3.06	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	34.65	5.45	1.73	2.60	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	21.51	1.79	1.02	1.54	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	27.75	4.77	1.19	2.39	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	49.85	11.33	2.27	4.53	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	53.70	6.14	6.90	3.07	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	43.05	4.45	3.71	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	67.70	16.08	6.77	2.54	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	42.20	14.07	2.11	5.63	4.22
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	51.37	9.34	7.47	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	40.71	9.27	4.12	2.58	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	53.53	9.52	8.33	3.57	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	58.81	11.54	7.69	4.75	1.81
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	46.82	6.69	4.07	2.33	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	51.77	5.40	5.40	3.60	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	69.50	13.01	7.05	5.01	1.63
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	60.60	10.78	7.19	4.62	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	44.81	5.29	5.29	2.82	3.18
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	38.65	6.66	4.00	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	76.92	14.77	5.09	3.06	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	54.16	6.94	6.94	2.13	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	59.52	11.15	3.78	2.65	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	75.47	15.34	7.98	7.98	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	65.23	14.68	4.89	2.45	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	45.40	7.50	7.29	2.50	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	56.33	8.13	6.17	3.36	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	56.67	7.21	4.12	3.09	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	54.29	9.87	4.06	2.90	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	52.01	7.77	3.89	5.38	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	47.58	7.19	5.53	3.87	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	60.45	9.54	7.78	3.89	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	65.27	12.54	4.43	3.32	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	46.05	10.36	5.76	4.61	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	70.61	9.59	5.76	2.30	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	71.33	9.06	2.83	2.83	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	65.64	9.03	2.46	2.46	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	58.29	7.68	3.16	4.97	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	50.27	7.90	5.75	3.59	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	55.27	7.47	0.75	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	66.52	14.12	7.06	3.72	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	48.24	3.02	3.45	2.58	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	57.37	4.28	1.71	2.57	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	49.31	6.66	5.66	2.00	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	56.11	9.65	2.41	3.62	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	50.48	7.82	4.98	2.13	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	57.74	5.16	7.22	4.12	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	51.53	3.76	3.76	2.15	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	47.14	6.06	4.04	6.06	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	57.41	9.63	6.30	2.22	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	60.47	11.63	8.14	2.33	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	56.06	7.40	5.29	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	62.82	5.60	4.40	3.20	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	67.60	18.17	4.36	2.18	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	69.75	14.56	9.20	5.37	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	78.43	9.37	7.40	4.44	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	65.87	6.59	5.65	4.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	76.43	11.56	6.03	3.52	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	72.55	11.27	6.76	3.60	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	75.73	5.16	12.05	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	76.15	11.58	12.91	3.12	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	75.47	12.90	5.47	5.08	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	70.59	13.85	3.96	1.98	5.94
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	80.43	11.42	9.34	5.19	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	63.45	10.50	6.13	3.94	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	61.50	13.98	5.03	5.03	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	79.05	11.92	5.74	5.30	4.42
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	68.66	10.03	5.79	4.63	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	64.81	8.61	4.56	3.54	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	70.17	11.05	3.36	2.88	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	75.14	11.13	5.17	3.58	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	78.99	6.68	7.29	4.25	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	66.40	5.53	4.84	2.77	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	75.62	12.54	6.08	3.04	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	87.27	17.56	6.71	5.16	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	78.61	5.44	4.23	1.81	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	77.01	12.68	5.07	5.07	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	82.63	11.73	4.26	6.93	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	78.16	8.05	6.32	6.90	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	86.39	15.94	7.20	6.69	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	79.93	10.61	5.66	4.24	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	83.99	5.11	8.51	5.11	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	68.23	17.47	6.24	5.41	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	68.12	8.61	13.31	5.48	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	59.29	10.86	2.09	7.52	2.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	71.09	8.83	7.43	2.79	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	68.24	9.37	6.02	3.35	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	56.67	3.74	5.88	4.28	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	63.85	10.10	2.83	2.83	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	57.82	9.18	6.42	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	54.24	7.11	5.33	6.22	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	72.37	7.41	4.56	2.85	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	65.95	6.14	3.83	2.30	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	56.36	4.38	2.74	1.64	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	63.70	6.24	2.67	3.12	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	80.33	10.66	3.38	3.90	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	61.67	4.64	3.32	5.97	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	64.44	10.39	4.16	0.00	6.24
Macrophage - monocyte derived, donor1	11232-116C8	23.93	1.14	7.07	0.91	0.68
Macrophage - monocyte derived, donor2	11313-117C8	28.63	2.39	2.94	2.02	1.10
Macrophage - monocyte derived, donor3	11389-118C3	27.53	3.15	5.51	1.05	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	32.92	2.66	3.72	2.66	0.00
Mallassez-derived cells, donor2	11929-125I3	16.95	3.96	3.64	0.48	0.95
Mallassez-derived cells, donor3	11930-125I4	20.01	2.64	4.17	1.67	0.28
Mammary Epithelial Cell, donor1	11273-116H4	34.48	3.19	3.59	1.49	0.90
Mammary Epithelial Cell, donor2	11350-117G9	29.24	3.76	5.21	1.16	1.74
Mammary Epithelial Cell, donor3	11422-118F9	23.20	1.75	2.74	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	23.05	15.59	2.71	2.03	0.00
Mast cell, donor1	11563-120D6	35.90	3.68	5.41	2.49	1.19
Mast cell, donor2	11565-120D8	41.01	4.16	5.35	1.78	1.19
Mast cell, donor3	11566-120D9	32.87	3.15	6.53	1.80	0.68
Mast cell, donor4	11567-120E1	36.52	4.61	5.14	1.77	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	43.47	5.54	3.33	2.66	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	49.03	16.34	1.75	5.25	0.58
Mast cell, expanded, donor5	11939-126A4	49.79	4.82	5.28	3.67	0.34
Mast cell, expanded, donor8	11941-126A6	36.49	4.69	6.53	1.00	0.00
Melanocyte - dark, donor1	11502-119F8	33.13	5.17	3.88	1.29	0.20
Melanocyte - dark, donor2	11582-120F7	28.03	3.46	4.15	1.04	0.69
Melanocyte - dark, donor3	11663-122F7	33.61	7.10	3.69	1.38	0.43
Melanocyte - light, donor1	11274-116H5	28.68	3.29	3.53	1.18	0.00
Melanocyte - light, donor2	11351-117H1	27.30	4.09	4.78	1.36	0.68
Melanocyte - light, donor3	11423-118G1	31.22	2.60	1.73	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	35.61	3.33	1.35	0.73	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	30.93	3.77	4.57	2.42	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	29.73	1.87	3.21	0.27	0.54
Meningeal Cells, donor1	11493-119E8	58.18	5.71	3.10	3.72	0.87
Meningeal Cells, donor2	11573-120E7	40.05	3.96	2.64	0.44	1.32
Meningeal Cells, donor3	11654-122E7	47.11	6.36	2.20	2.61	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	26.52	2.00	2.28	1.14	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.66	4.73	3.72	0.91	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	44.68	1.31	5.26	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	27.47	2.62	2.62	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.14	2.87	0.72	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	23.93	2.33	1.91	1.06	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	26.14	1.51	2.51	2.51	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	44.83	5.05	2.64	1.98	1.54
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	37.26	2.92	1.46	0.73	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	41.53	5.73	5.52	1.23	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	20.36	0.97	2.08	1.25	1.25
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	46.47	6.69	5.58	2.60	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	29.08	2.37	1.84	0.53	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	38.28	2.08	4.45	1.19	2.08
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	2.34	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	33.30	3.84	3.20	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	38.63	5.32	2.84	1.77	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	25.02	2.19	2.81	0.31	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.01	2.18	2.18	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	18.30	3.98	5.83	0.27	0.53
Mesothelial Cells, donor2	12156-128G5	19.02	2.50	5.51	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	22.84	2.89	4.34	0.87	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	0.00	9.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	23.64	0.99	7.39	0.25	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	27.68	2.65	7.07	2.36	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	10.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	17.67	1.55	7.13	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	21.16	4.56	5.60	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	20.77	1.75	8.26	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	15.36	1.40	4.19	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	18.49	2.44	9.55	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	28.11	3.17	6.73	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.93	0.88	5.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	28.88	2.66	5.32	2.66	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	11.67	1.49	3.40	0.21	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	0.00	4.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.75	0.60	2.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	0.00	5.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.79	1.76	3.26	1.51	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	11.41	1.66	3.09	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.87	0.00	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.60	2.07	2.53	0.46	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.41	1.47	3.58	0.42	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.38	1.02	2.85	0.20	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.52	1.72	2.15	0.86	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.11	1.11	4.00	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.67	1.31	2.19	0.88	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.03	1.01	2.03	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.96	1.90	2.72	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.70	2.06	2.94	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.66	6.25	5.29	0.96	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	15.61	2.40	3.20	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	1.37	1.37	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	31.54	6.01	5.01	1.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	2.04	2.04	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	25.40	5.69	4.38	3.94	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	3.20	1.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	27.77	8.43	4.21	1.74	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	4.18	4.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	2.21	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	22.56	5.13	6.84	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.07	2.19	3.94	0.00	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	6.39	1.78	3.91	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	32.54	4.77	7.29	0.84	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.98	1.25	2.08	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	1.17	2.91	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	27.45	3.92	6.64	1.51	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	27.97	4.59	6.68	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	3.69	2.77	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	20.49	2.28	7.40	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.40	1.66	2.90	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	29.80	4.15	7.00	1.30	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.44	2.14	3.86	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.72	0.00	3.81	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	18.42	1.87	5.34	1.87	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	25.14	1.80	14.07	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.17	1.27	5.09	0.57	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	27.39	4.78	7.96	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.67	2.43	8.62	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.86	1.52	3.03	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.73	3.98	9.09	1.42	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	27.04	1.72	9.09	1.23	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	0.65	6.52	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	14.70	2.94	7.35	1.18	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.97	3.75	10.09	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	15.25	2.06	10.72	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	23.52	1.79	9.53	0.89	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	1.78	7.13	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	22.34	2.96	9.53	1.64	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	2.10	8.42	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	23.33	2.37	9.09	0.79	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	29.80	5.59	4.66	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	24.78	4.51	8.64	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.11	1.33	5.59	1.33	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.55	1.24	6.11	0.34	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	19.89	2.21	3.68	2.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.22	2.56	10.26	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	3.11	7.78	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	1.07	3.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	0.00	4.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.28	0.42	2.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	1.36	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	1.91	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	4.75	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	28.87	4.09	3.02	1.29	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	22.47	5.23	2.61	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.68	0.67	2.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	9.60	2.09	1.25	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	14.64	1.71	0.95	0.76	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	11.17	4.79	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.92	0.68	2.72	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.83	2.09	1.67	1.26	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	15.34	3.02	1.39	1.16	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.62	3.24	0.81	0.27	1.62
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	25.23	1.05	3.36	0.42	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	20.85	2.98	1.99	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.35	2.98	2.44	0.27	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	18.59	2.95	2.95	0.00	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	22.54	0.98	2.94	0.16	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.50	2.00	1.82	0.55	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	24.93	0.53	0.53	0.53	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	1.20	1.80	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	5.58	0.33	1.64	0.66	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.22	0.98	2.44	0.49	0.98
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.40	1.23	1.23	1.41	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.88	2.81	1.41	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.39	2.76	1.38	0.92	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	28.60	1.93	2.89	0.64	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	4.48	0.34	1.38	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.04	1.11	2.23	0.22	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	18.21	2.12	2.96	0.42	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	11.39	0.71	2.37	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	25.33	1.72	2.58	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	23.33	1.00	2.67	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.02	2.71	0.90	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.22	3.97	1.59	0.40	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	28.79	1.86	0.00	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	22.70	0.76	2.27	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	18.90	2.93	2.61	0.65	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.00	0.87	1.31	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	11.31	1.81	2.71	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.93	4.41	4.41	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.26	0.66	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	28.77	1.98	1.98	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.55	0.77	2.68	0.77	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	39.92	2.42	3.33	0.60	1.51
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	23.87	2.43	1.11	0.22	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	26.43	2.71	2.03	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	35.36	2.44	1.83	0.00	4.88
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.53	1.26	1.89	0.31	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.58	1.21	1.82	0.30	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	21.36	2.37	2.37	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	11.34	2.27	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	0.00	0.00	5.06
Myoblast, donor1	11241-116D8	25.09	3.73	3.98	1.86	0.37
Myoblast, donor2	11322-117D8	37.40	4.79	1.92	1.34	0.96
Myoblast, donor3	11398-118D3	24.05	2.52	2.86	0.84	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	41.30	6.86	6.57	1.46	0.88
Natural Killer Cells, donor1	11230-116C6	19.37	4.92	4.00	1.23	0.31
Natural Killer Cells, donor2	11311-117C6	13.87	0.90	4.52	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	17.67	1.84	2.94	1.10	0.00
Neural stem cells, donor1	11275-116H6	57.71	6.53	2.54	3.63	1.81
Neural stem cells, donor2	11352-117H2	50.07	1.93	0.00	1.93	1.93
Neurons, donor1	11494-119E9	55.76	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	53.06	0.44	2.42	0.44	1.98
Neurons, donor3	11655-122E8	55.91	1.64	3.29	0.00	1.64
Neutrophils, donor1	11233-116C9	38.98	3.71	9.28	2.78	0.00
Neutrophils, donor2	11314-117C9	26.09	8.70	8.70	2.90	0.00
Neutrophils, donor3	11390-118C4	58.64	8.55	18.33	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	27.43	1.54	3.32	0.59	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	20.51	3.26	1.30	0.33	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	23.06	2.21	1.40	0.40	0.60
Olfactory epithelial cells, donor1	11933-125I7	22.02	1.10	1.51	0.55	1.65
Olfactory epithelial cells, donor2	11934-125I8	15.92	1.74	1.30	0.58	0.43
Olfactory epithelial cells, donor3	11935-125I9	21.45	1.36	1.93	0.57	1.02
Olfactory epithelial cells, donor4	11936-126A1	27.17	2.34	1.75	0.19	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	27.68	1.81	5.42	1.20	1.20
Osteoblast - differentiated, donor1	11276-116H7	19.14	1.28	2.13	0.85	0.64
Osteoblast - differentiated, donor2	11353-117H3	33.15	0.00	8.00	0.00	3.43
Osteoblast - differentiated, donor3	11425-118G3	23.59	3.72	2.48	0.62	2.48
Osteoblast, donor1	11277-116H8	45.93	5.28	3.32	1.37	1.56
Osteoblast, donor2	11354-117H4	25.28	4.21	2.81	1.40	1.40
Osteoblast, donor3	11426-118G4	44.25	5.87	3.91	1.07	1.24
Pancreatic stromal cells, donor1	11249-116E7	24.01	3.29	2.86	0.84	0.84
Pericytes, donor1	11491-119E6	27.82	1.67	3.89	1.11	1.78
Pericytes, donor2	11571-120E5	39.39	3.62	3.40	1.36	2.26
Pericytes, donor3	11652-122E5	40.08	5.49	2.85	3.46	1.22
Perineurial Cells, donor1	11499-119F5	27.24	3.39	0.90	1.13	0.90
Perineurial Cells, donor2	11579-120F4	26.68	3.68	4.32	1.10	0.92
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	28.05	3.51	7.97	1.59	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	22.53	1.71	4.41	0.73	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	19.15	2.07	4.66	0.78	0.13
Placental Epithelial Cells, donor1	11278-116H9	42.57	3.35	6.94	1.20	1.67
Placental Epithelial Cells, donor2	11355-117H5	44.36	3.33	7.76	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	38.68	2.75	4.32	0.98	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	20.57	1.27	1.58	1.27	0.32
Preadipocyte - breast, donor1	11467-119B9	21.38	2.81	4.31	0.75	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	31.46	2.61	2.35	0.78	0.65
Preadipocyte - breast, donor2	11328-117E5	29.72	3.15	2.25	1.35	1.13
Preadipocyte - omental, donor1	11468-119C1	22.91	2.24	2.13	0.96	0.32
Preadipocyte - omental, donor2	11329-117E6	20.51	0.00	3.49	2.62	0.00
Preadipocyte - omental, donor3	11403-118D8	35.67	3.72	2.58	1.15	1.43
Preadipocyte - perirenal, donor1	11469-119C2	37.40	3.94	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	42.69	9.83	3.99	1.84	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	44.45	9.56	3.54	1.77	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	40.53	6.30	3.75	0.85	0.85
Preadipocyte - visceral, donor1	11280-116I2	35.77	4.84	3.82	1.86	0.47
Preadipocyte - visceral, donor2	11357-117H7	38.19	5.98	2.30	0.92	1.38
Preadipocyte - visceral, donor3	11429-118G7	31.03	1.46	2.82	1.99	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	36.66	8.00	2.41	1.96	1.06
Prostate Epithelial Cells, donor2	11331-117E8	26.54	2.57	6.64	1.22	0.41
Prostate Epithelial Cells, donor3	11404-118D9	17.09	0.98	1.53	0.43	0.67
Prostate Stromal Cells, donor1	11254-116F3	30.41	4.44	2.96	1.48	0.34
Prostate Stromal Cells, donor2	11332-117E9	32.81	8.43	2.33	1.61	0.36
Prostate Stromal Cells, donor3	11405-118E1	25.76	2.40	3.44	0.63	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	46.35	4.74	1.82	1.46	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	34.73	2.43	2.84	0.69	0.62
Renal Epithelial Cells, donor1	11517-119H5	59.35	6.09	1.52	1.01	3.04
Renal Epithelial Cells, donor2	11597-120H4	54.77	2.85	0.71	1.42	4.27
Renal Epithelial Cells, donor3	11678-122H4	38.96	1.91	3.07	0.53	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	46.98	4.77	4.09	5.45	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	50.27	7.01	3.37	2.83	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	27.97	3.55	2.66	2.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	62.55	5.32	3.33	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	44.02	3.08	4.18	0.66	1.98
Renal Mesangial Cells, donor2	11598-120H5	43.89	3.76	1.25	2.51	1.25
Renal Mesangial Cells, donor3	11679-122H5	41.06	1.11	5.27	1.66	1.94
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	48.85	3.76	2.95	1.34	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	33.74	6.33	2.95	0.84	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	49.37	3.47	3.86	1.93	1.35
Retinal Pigment Epithelial Cells, donor0	11215-116A9	29.04	2.07	2.07	0.00	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	40.65	3.70	3.41	0.85	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	24.70	4.12	4.12	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	31.36	4.27	3.76	0.50	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	30.47	6.82	2.94	2.27	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	54.50	0.89	0.00	2.68	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	66.59	3.85	1.65	3.85	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	46.40	4.64	3.48	4.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	51.36	1.69	1.17	1.69	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	78.05	5.36	2.18	3.97	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	107.86	6.92	2.79	4.91	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	82.98	3.35	1.98	3.47	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	87.76	5.36	3.61	3.03	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	110.71	5.78	3.00	2.54	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	63.66	3.29	1.78	2.05	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	70.95	4.99	2.57	2.57	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	96.76	5.73	1.79	3.40	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	72.45	2.87	2.30	1.72	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	81.13	4.29	2.68	3.86	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	98.47	5.31	3.76	2.43	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	43.97	1.72	2.10	1.34	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	61.02	3.91	2.14	2.89	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	94.89	6.39	2.63	3.57	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	44.19	2.26	1.99	1.59	1.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	74.47	3.50	2.04	2.43	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	99.87	7.07	2.29	2.67	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	59.16	4.27	1.92	2.56	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	63.35	7.57	2.52	2.80	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	85.62	6.32	2.22	2.73	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	54.70	2.92	1.64	2.92	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	76.03	5.03	3.31	3.31	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	100.47	6.04	2.42	3.63	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	92.23	5.90	3.30	5.90	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	72.82	6.35	2.78	3.77	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	110.61	6.31	2.10	4.21	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	88.96	6.43	3.94	3.53	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	66.36	6.64	1.77	3.10	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	107.58	10.24	3.76	2.72	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	91.52	5.52	3.63	5.11	3.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	60.62	5.45	1.87	2.90	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	112.01	8.68	3.66	3.66	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	70.32	6.19	1.89	3.61	3.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	62.00	3.84	3.15	2.74	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	84.22	6.57	2.30	3.61	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	70.05	2.56	1.36	1.19	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	88.92	5.03	2.07	3.11	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	74.10	3.73	2.13	2.93	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	60.56	3.32	1.38	2.21	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	89.76	4.29	1.43	4.05	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	85.66	3.22	2.82	3.22	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	66.02	3.11	1.70	2.92	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	83.85	6.64	1.40	2.45	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	62.86	6.04	3.02	2.72	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	66.82	3.43	1.22	3.67	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	91.84	8.73	4.66	4.95	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	91.87	5.48	0.61	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	55.16	3.62	3.01	3.92	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	103.59	5.20	4.52	4.52	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	111.43	5.69	2.40	3.29	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	73.21	4.49	1.53	2.48	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	87.94	8.75	3.84	3.84	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	87.74	3.00	1.20	2.40	0.60
Schwann Cells, donor1	11498-119F4	49.65	4.89	1.69	1.50	1.13
Schwann Cells, donor2	11578-120F3	27.22	6.80	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	31.99	1.75	2.19	0.66	0.88
Sebocyte, donor1	11220-116B5	37.80	1.64	4.38	3.83	0.00
Sebocyte, donor2	11301-117B5	25.74	2.76	2.76	0.92	1.84
Sebocyte, donor3	11378-118B1	32.98	2.27	3.09	0.41	1.86
Sertoli Cells, donor1	11255-116F4	48.04	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	28.24	5.65	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	41.61	3.26	2.46	1.94	0.79
Skeletal Muscle Cells, donor2	11358-117H8	28.91	15.18	4.34	0.00	2.17
Skeletal Muscle Cells, donor3	11430-118G8	57.69	9.20	0.84	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	36.60	1.89	3.77	1.89	1.26
Skeletal Muscle Cells, donor5	11455-119A6	33.74	2.97	1.34	1.64	1.34
Skeletal Muscle Cells, donor6	11459-119B1	37.55	3.23	2.15	1.08	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	31.75	2.90	3.91	0.50	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	26.54	2.28	5.42	0.71	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	53.28	5.75	3.27	1.19	1.49
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	41.11	3.88	2.11	1.18	1.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	36.19	3.62	2.90	0.72	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	27.24	2.20	3.58	0.69	0.69
Skin - palm, donor1	10286-104F7	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	30.71	2.45	2.31	0.72	1.01
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	116.14	15.54	4.91	4.91	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	31.81	1.95	1.30	0.65	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	26.97	4.03	3.75	0.70	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	24.47	5.34	3.09	1.69	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	113.33	9.52	4.86	2.75	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	25.93	2.70	2.10	0.60	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.06	1.54	2.16	1.23	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	29.79	2.89	2.67	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	35.86	5.29	4.70	2.35	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	34.70	4.42	2.87	1.55	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	26.38	6.30	3.15	1.97	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	39.40	4.64	1.55	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	24.02	6.00	7.01	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	25.55	5.59	2.66	1.33	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	26.60	5.76	3.10	1.11	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.77	4.35	3.33	1.02	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	31.58	2.93	3.91	1.95	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	31.30	2.66	2.95	1.48	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	24.20	3.99	3.27	0.85	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	40.51	3.74	4.23	1.79	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.92	1.83	2.44	0.00	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	34.10	3.54	5.30	1.52	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	22.89	2.38	1.91	0.95	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	23.60	2.65	1.92	0.59	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.27	4.95	3.01	0.86	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	33.48	4.51	3.04	0.94	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	28.00	7.89	4.02	1.39	1.08
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	28.02	7.55	7.55	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	34.37	3.59	2.99	1.49	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	51.55	4.78	4.10	2.05	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	24.11	1.96	2.04	0.71	0.94
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	22.85	2.82	3.32	1.41	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	36.86	5.92	4.32	1.82	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	22.34	4.23	1.81	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	40.80	6.36	3.97	0.53	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	20.51	2.40	1.46	0.27	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	26.42	2.75	2.00	1.00	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	13.44	1.27	4.57	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	33.47	5.43	3.02	0.60	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	34.51	1.50	3.00	1.50	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	31.01	3.88	3.88	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	41.86	8.37	4.19	2.33	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	26.25	5.05	2.52	2.52	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	28.52	1.25	3.45	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.37	2.06	4.13	1.77	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	29.82	2.58	3.83	1.33	1.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	16.35	1.40	4.67	0.93	2.80
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	21.59	3.74	2.30	0.43	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	31.87	7.39	5.10	1.53	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	33.66	3.95	2.63	0.75	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	28.23	2.38	2.66	0.84	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.57	2.85	2.01	0.34	0.92
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	29.05	5.24	2.38	1.90	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.33	3.18	1.47	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	27.18	2.43	2.65	1.99	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.97	2.34	2.05	1.17	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	22.55	0.97	3.11	0.78	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	11.37	1.85	2.38	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.90	2.23	1.49	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.25	2.16	2.52	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	18.17	1.14	2.84	0.85	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	31.12	2.36	2.76	1.18	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	15.24	1.27	1.02	0.25	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	13.58	1.20	2.00	0.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	18.81	2.51	0.42	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	22.92	1.38	2.75	0.00	0.92
Synoviocyte, donor1	11291-117A4	32.49	4.21	3.53	1.18	0.50
Synoviocyte, donor2	11368-117I9	25.31	2.68	1.84	0.84	0.17
Synoviocyte, donor3	11440-118H9	21.00	2.01	1.12	0.89	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	77.18	7.50	5.72	2.50	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	53.52	5.95	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	53.95	3.24	5.79	1.39	2.08
Tracheal Epithelial Cells, donor1	11292-117A5	29.10	4.30	2.87	0.79	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	30.54	5.80	3.48	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	32.64	4.58	2.29	1.15	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	30.76	8.37	3.57	1.48	0.37
Urethra, donor2	10319-105A4	23.38	0.00	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	34.54	6.11	4.25	1.59	0.00
Urothelial Cells, donor2	11600-120H7	26.84	2.40	4.41	1.20	1.20
Urothelial Cells, donor3	11681-122H7	27.96	2.52	3.44	0.23	0.46
Urothelial cells, donor0	11216-116B1	36.33	4.46	4.90	0.89	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	74.74	7.12	32.92	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	90.07	0.00	30.02	5.72	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	62.29	6.16	16.43	2.74	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	67.83	3.44	15.84	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	83.67	6.39	17.43	5.81	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	62.47	4.16	12.49	6.25	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	83.52	6.42	20.19	4.59	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	64.82	1.83	16.43	2.74	0.91
Wilms' tumor cell line:G-401	10809-111A8	54.28	9.38	3.82	1.85	1.48
Wilms' tumor cell line:HFWT	10597-108E3	12.32	1.76	0.88	2.64	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	49.72	8.10	5.59	1.96	1.12
achilles tendon, donor2	10292-104G4	10.33	0.00	4.13	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	63.99	3.31	4.84	2.55	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	81.96	6.27	5.11	1.63	3.02
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	91.76	2.14	3.09	0.71	2.02
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	72.11	1.90	2.72	1.36	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	106.25	10.40	5.06	4.22	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	69.37	6.56	4.23	2.11	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	71.59	10.07	7.08	3.81	2.45
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	61.69	6.61	3.97	3.53	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	91.06	2.86	2.45	0.00	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	83.87	7.77	4.66	1.55	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	76.36	2.39	2.94	1.47	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	93.61	7.80	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	57.86	5.34	3.02	1.86	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	106.41	6.47	3.37	3.11	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	114.56	3.80	6.72	4.38	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	33.93	1.39	6.04	0.93	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	78.96	4.11	3.70	2.88	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	30.70	3.07	0.61	0.31	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	28.16	3.41	2.13	1.71	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	35.79	1.82	3.03	1.21	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	41.40	4.57	3.85	1.20	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	90.65	4.68	6.01	3.56	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	46.70	4.00	3.34	2.33	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	88.14	4.90	1.51	3.39	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	50.59	6.11	2.62	3.93	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	24.37	3.75	1.87	1.87	3.75
adenocarcinoma cell line:IM95m	10796-110I4	28.73	4.95	1.41	1.18	0.71
adipose tissue, adult, pool1	10010-101C1	20.79	1.09	2.48	0.78	0.62
adipose, donor1	10184-103D4	26.97	1.76	2.35	0.59	3.52
adipose, donor2	10185-103D5	50.69	4.46	1.22	0.00	2.03
adipose, donor3	10186-103D6	49.01	2.45	0.82	1.09	1.91
adipose, donor4	10187-103D7	36.40	2.60	2.60	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	46.24	3.95	2.68	0.95	2.21
adrenal gland, adult, pool1	10081-102A9	21.83	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	46.69	2.00	5.60	0.80	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	16.79	2.50	2.14	0.71	0.36
amniotic membrane cells, donor1	12235-129G3	18.55	1.62	4.17	0.46	0.70
amniotic membrane cells, donor2	12236-129G4	35.50	0.34	2.03	2.03	1.01
amniotic membrane cells, donor3	12237-129G5	17.97	0.59	1.77	0.00	0.29
amygdala - adult, donor10196	10167-103B5	20.16	1.19	5.93	0.00	0.00
amygdala, adult, donor10252	10151-102I7	37.11	2.03	3.85	0.81	0.00
amygdala, newborn, donor10223	10360-105E9	23.56	2.90	3.87	0.32	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	52.08	6.88	2.80	1.78	1.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	55.38	4.85	10.15	1.32	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	50.44	9.69	4.01	2.67	1.00
aorta, adult, pool1	10052-101G7	23.14	2.55	1.77	0.59	1.57
appendix, adult	10189-103D9	33.77	3.49	6.60	1.16	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	61.22	8.25	5.85	2.06	2.75
artery, adult	10190-103E1	16.30	0.00	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	43.75	2.32	5.07	0.72	1.01
b cell line:RPMI1788	10427-106D4	38.96	6.99	4.31	1.19	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.03	1.94	2.50	1.39	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	37.71	7.14	2.48	1.39	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	45.69	11.21	4.02	1.51	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	71.02	4.47	8.39	0.00	2.80
bladder, adult, pool1	10011-101C2	19.88	1.85	1.20	0.11	0.65
blood, adult, pool1	10053-101G8	46.51	8.86	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	8.56	0.00	0.86	1.71	0.00
bone marrow, adult	10192-103E3	20.92	0.67	4.72	0.67	0.00
brain, adult, donor1	10084-102B3	34.85	1.03	2.05	1.03	0.00
brain, adult, pool1	10012-101C3	23.61	2.00	3.23	0.78	0.22
brain, fetal, pool1	10085-102B4	50.76	0.00	8.01	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	30.39	6.28	3.63	1.98	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	50.43	6.62	6.12	2.12	0.50
breast, adult, donor1	10080-102A8	17.68	0.63	1.26	0.63	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	19.69	1.65	1.52	0.25	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	39.89	3.71	7.11	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	80.81	2.76	6.22	1.61	2.99
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	33.89	2.18	3.63	0.97	0.97
carcinoid cell line:NCI-H1770	10703-109H1	41.37	0.94	0.00	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	33.36	8.64	6.23	1.31	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	38.98	0.63	1.90	0.32	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	62.02	5.32	2.66	1.33	1.86
caudate nucleus - adult, donor10196	10177-103C6	23.03	0.00	1.15	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	32.29	2.84	4.02	0.17	0.67
caudate nucleus, adult, donor10258	10379-105H1	18.34	0.76	3.82	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	24.54	1.83	2.56	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	55.35	2.91	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	58.07	2.14	4.06	0.64	1.92
cerebellum, adult, pool1	10083-102B2	29.67	2.76	1.72	1.38	0.34
cerebellum, newborn, donor10223	10357-105E6	32.38	1.66	3.32	0.83	0.83
cerebral meninges, adult	10188-103D8	18.41	0.76	3.03	0.25	0.50
cerebrospinal fluid, donor2	10294-104G6	6.58	0.00	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	87.56	14.95	6.61	7.19	2.73
cervical cancer cell line:ME-180	10553-107I4	22.54	2.32	5.97	0.66	0.33
cervix, adult, pool1	10013-101C4	33.39	4.09	3.46	1.36	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	37.62	8.64	2.79	1.81	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	65.74	6.71	2.61	1.99	1.86
choriocarcinoma cell line:SCH	10785-110H2	72.82	5.67	2.34	1.48	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	23.95	1.19	1.90	0.47	1.19
chorionic membrane cells, donor1	12238-129G6	23.93	0.57	3.13	0.28	1.42
chorionic membrane cells, donor2	12239-129G7	40.77	2.88	4.28	1.39	0.60
chorionic membrane cells, donor3	12240-129G8	25.83	0.55	4.40	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	58.57	1.01	7.07	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	60.70	9.22	5.57	3.07	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	58.08	4.65	7.81	4.65	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	94.50	7.96	6.16	2.82	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	108.60	9.68	7.74	3.39	2.66
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	103.03	8.55	7.74	2.44	2.04
chronic myelogenous leukemia cell line:K562	10454-106G4	63.31	2.65	5.89	1.47	2.06
chronic myelogenous leukemia cell line:KU812	10409-106B4	114.15	7.30	3.91	4.95	2.09
clear cell carcinoma cell line:JHOC-5	10638-108I8	46.63	5.26	5.49	1.37	0.46
clear cell carcinoma cell line:TEN	10636-108I6	14.40	5.38	1.21	0.69	0.17
colon carcinoma cell line:CACO-2	10513-107D9	30.38	3.48	2.56	1.46	1.10
colon carcinoma cell line:COLO-320	10420-106C6	66.51	2.66	1.90	0.76	3.80
colon, adult, donor1	10082-102B1	32.13	1.19	4.76	1.19	0.00
colon, adult, pool1	10014-101C5	25.03	6.70	4.11	2.59	0.59
colon, fetal, donor1	10070-101I7	17.30	1.85	3.09	1.24	1.24
common myeloid progenitor CMP, donor1	12130-128D6	105.42	9.17	4.58	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	81.16	14.45	2.12	2.97	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	58.11	11.02	1.96	3.62	1.21
cord blood derived cell line:COBL-a untreated	10449-106F8	68.53	10.58	4.23	3.81	1.13
corpus callosum, adult, pool1	10042-101F6	39.03	2.43	2.10	1.22	1.33
cruciate ligament, donor2	10295-104G7	12.97	0.81	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	32.10	1.61	0.80	1.61	0.00
diencephalon, adult	10193-103E4	16.08	0.72	1.44	0.72	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	54.19	4.59	3.90	3.21	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	27.95	2.82	3.85	1.03	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	36.83	4.81	3.85	0.96	0.72
ductus deferens, adult	10196-103E7	60.30	6.48	8.47	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	10.08	1.44	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	55.91	5.15	4.41	1.47	0.00
dura mater, adult, donor1	10041-101F5	18.50	3.30	2.64	1.82	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	158.12	17.99	23.10	2.22	5.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	76.23	3.73	2.29	2.01	1.58
embryonic pancreas cell line:1B2C6	10604-108F1	12.33	1.23	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	26.34	2.12	2.12	0.30	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	14.51	2.16	1.85	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	13.13	1.31	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	38.55	4.02	3.69	1.68	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	45.13	5.80	2.90	2.36	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	30.88	1.77	2.25	0.80	0.80
epidermoid carcinoma cell line:A431	10426-106D3	27.01	5.67	2.33	1.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	42.67	3.85	3.52	1.43	0.44
epididymis, adult	10197-103E8	36.21	7.33	4.81	1.67	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	30.87	1.60	1.77	0.71	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	20.84	23.99	1.97	1.18	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	83.22	8.39	3.41	4.19	1.70
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	88.97	8.86	5.31	3.74	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	88.95	8.29	4.15	5.04	2.02
esophagus, adult, pool1	10015-101C6	16.46	1.81	1.59	0.00	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	41.45	3.88	3.01	1.25	1.13
eye - muscle inferior rectus, donor1	10272-104E2	7.24	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	2.10	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	4.46	0.00	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	19.49	2.29	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	13.12	0.00	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	19.83	0.51	2.29	0.00	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	43.85	2.95	1.92	1.03	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	54.84	4.51	7.12	2.61	1.19
frontal lobe, adult, pool1	10040-101F4	31.06	2.06	3.47	1.60	0.94
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	41.13	9.61	5.40	1.20	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	43.25	9.88	3.29	1.92	0.91
gall bladder, adult	10198-103E9	34.77	4.35	1.93	0.48	0.48
gamma delta positive T cells, donor1	11937-126A2	68.72	5.91	10.20	1.61	0.54
gamma delta positive T cells, donor2	11938-126A3	35.11	4.48	5.23	2.61	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	39.08	7.82	3.38	2.11	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	58.41	8.90	5.61	2.13	2.13
gastric cancer cell line:AZ521	10549-107H9	55.25	5.90	4.10	2.30	2.13
gastric cancer cell line:GSS	10560-108A2	63.15	3.66	7.32	2.75	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	45.01	13.94	3.88	2.06	0.23
giant cell carcinoma cell line:LU65	10487-107B1	50.94	3.21	1.49	1.72	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	60.88	4.20	7.14	1.54	1.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	17.21	2.24	1.75	0.25	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	22.90	3.06	2.22	0.95	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	22.61	1.97	1.83	0.84	0.70
glioblastoma cell line:T98G	10485-107A8	39.29	2.54	4.41	1.55	1.21
glioma cell line:GI-1	10413-106B8	34.27	15.23	1.76	1.17	1.17
globus pallidus - adult, donor10196	10175-103C4	16.04	0.73	0.73	0.00	1.46
globus pallidus, adult, donor10252	10161-103A8	53.94	3.91	1.46	0.49	0.98
globus pallidus, adult, donor10258	10367-105F7	19.17	2.74	2.74	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	28.24	2.66	0.53	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	78.31	14.68	4.89	2.45	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	15.68	5.23	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	21.44	3.20	1.60	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	54.63	4.59	3.67	1.38	1.84
hIPS +CCl2, biol_rep2	14384-156C1	60.36	2.29	1.37	0.00	2.29
hIPS +CCl2, biol_rep3	14385-156C2	53.46	5.15	5.15	0.00	3.22
hIPS, biol_rep1	14380-156B6	47.43	1.44	1.44	0.00	2.87
hIPS, biol_rep2	14381-156B7	59.67	4.12	4.12	1.37	2.06
hIPS, biol_rep3	14382-156B8	19.86	2.21	2.21	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	36.78	2.59	2.87	1.15	1.15
heart - mitral valve, adult	10205-103F7	32.89	1.20	1.79	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	30.59	2.61	1.83	0.26	1.05
heart - tricuspid valve, adult	10207-103F9	35.80	6.66	1.67	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	33.26	3.26	4.90	1.22	0.41
heart, adult, diseased, donor1	10051-101G6	19.59	1.70	5.11	1.28	0.85
heart, adult, pool1	10016-101C7	18.40	1.61	0.92	0.00	0.46
heart, fetal, pool1	10046-101G1	39.22	2.57	4.62	0.72	1.33
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.68	1.54	2.47	0.93	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	21.41	5.95	3.57	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	81.10	32.60	3.09	5.75	2.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	84.96	32.29	5.22	6.19	1.94
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	94.08	34.26	3.64	7.17	1.72
hepatoma cell line:Li-7	10484-107A7	32.47	5.00	3.67	1.00	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	43.32	6.73	3.32	1.51	1.31
hippocampus - adult, donor10196	10169-103B7	25.55	0.00	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	37.15	2.04	3.06	0.20	0.61
hippocampus, adult, donor10258	10374-105G5	24.40	1.49	6.47	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	29.61	1.76	1.76	0.70	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	75.07	1.22	3.05	1.83	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	83.84	2.16	4.52	1.18	3.93
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	80.48	2.54	1.78	0.76	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	79.50	1.69	1.69	1.13	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	72.82	3.10	3.61	0.77	4.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	85.79	3.80	7.21	1.14	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	70.07	4.38	3.21	1.75	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	63.98	3.88	2.15	0.86	2.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	69.65	3.34	1.67	1.67	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	76.48	4.97	3.55	5.68	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	61.72	6.11	3.86	3.86	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	74.06	4.71	2.69	0.67	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	67.91	1.72	1.72	0.63	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	59.45	2.95	4.42	0.98	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	47.13	1.75	3.49	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	76.36	2.67	2.29	1.53	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	70.21	2.62	1.74	0.87	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	54.47	3.00	1.00	1.50	3.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	53.13	2.45	2.45	1.32	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	61.84	3.18	4.55	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	48.55	2.51	1.88	0.63	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	50.30	4.74	3.10	2.29	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	58.06	3.19	4.06	2.03	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	62.77	5.68	2.39	3.59	3.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	84.24	3.69	4.25	0.74	2.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	70.18	2.00	2.00	0.57	3.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	66.55	4.08	3.67	1.22	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	49.29	2.11	3.87	0.70	2.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	66.83	3.80	2.85	0.95	4.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	67.79	2.42	3.33	1.21	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	53.26	1.03	3.10	1.55	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	55.13	3.98	3.32	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	47.97	2.05	3.59	1.28	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	47.29	5.88	2.30	1.79	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	56.03	8.33	3.79	6.06	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	50.41	3.70	2.02	3.02	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	76.07	4.11	5.55	2.42	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	72.20	4.90	3.12	1.78	3.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	83.42	3.41	2.44	1.46	5.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	65.10	3.06	2.14	0.61	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	74.82	3.25	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	57.58	2.65	3.64	1.65	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	59.11	1.64	2.74	0.55	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	49.94	3.26	2.90	1.45	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	54.45	4.98	2.85	1.42	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	40.58	7.16	3.58	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	66.76	4.47	4.47	1.22	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	46.87	2.96	4.04	2.69	0.27
immature langerhans cells, donor1	11904-125F5	17.43	3.15	2.42	1.45	0.24
immature langerhans cells, donor2	11905-125F6	24.56	6.34	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	35.96	2.27	7.10	1.89	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	34.14	2.60	2.60	0.33	1.63
kidney, adult, pool1	10017-101C8	21.23	6.01	3.60	1.00	0.10
kidney, fetal, pool1	10045-101F9	44.99	5.09	5.23	1.20	1.27
large cell lung carcinoma cell line:IA-LM	10509-107D5	65.33	7.95	15.05	3.12	1.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	35.11	6.36	2.35	1.24	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	24.77	5.69	3.67	1.28	0.00
left atrium, adult, donor1	10079-102A7	15.26	1.09	2.72	0.00	0.54
left ventricle, adult, donor1	10078-102A6	9.10	1.01	1.01	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	26.54	3.83	2.19	0.82	0.82
leiomyoma cell line:10964C	10569-108B2	17.96	3.95	4.67	1.44	1.08
leiomyoma cell line:15242A	10570-108B3	28.80	3.80	3.80	1.09	0.54
leiomyoma cell line:15425	10571-108B4	25.98	3.16	5.10	0.97	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	17.77	5.23	1.05	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	104.84	10.63	7.44	3.19	1.18
liposarcoma cell line:KMLS-1	10782-110G8	30.15	2.34	2.66	1.25	0.47
liposarcoma cell line:SW 872	10726-110A6	44.35	6.46	4.14	1.58	1.10
liver, adult, pool1	10018-101C9	28.52	20.42	3.40	2.59	0.49
liver, fetal, pool1	10086-102B5	15.99	5.64	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	21.14	1.90	1.60	0.44	0.29
locus coeruleus, adult, donor10252	10165-103B3	41.15	3.88	4.43	0.74	0.74
locus coeruleus, adult, donor10258	10375-105G6	24.26	2.26	2.26	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	20.19	1.68	3.36	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	16.88	14.81	3.88	0.97	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	19.30	1.38	7.58	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	36.25	6.20	7.78	1.58	0.92
lung, adult, pool1	10019-101D1	21.97	2.01	2.48	0.71	0.24
lung, fetal, donor1	10068-101I5	48.80	1.14	2.57	0.57	0.86
lung, right lower lobe, adult, donor1	10075-102A3	35.74	4.12	3.21	0.46	0.92
lymph node, adult, donor1	10077-102A5	35.50	4.26	4.26	2.84	1.89
lymphangiectasia cell line:DS-1	10727-110A7	38.58	6.58	5.92	1.53	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	42.71	3.02	4.68	1.81	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	23.79	2.55	8.49	0.00	0.00
mature adipocyte, donor1	12231-129F8	8.44	0.44	2.22	0.00	0.44
mature adipocyte, donor2	12232-129F9	11.00	0.83	1.87	1.04	0.00
mature adipocyte, donor3	12233-129G1	10.43	1.42	1.42	0.24	0.47
mature adipocyte, donor4	12234-129G2	8.42	0.53	1.58	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	40.74	13.10	5.24	3.34	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	31.58	0.00	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	38.07	1.29	5.15	1.84	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	19.70	1.59	5.40	0.95	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	15.78	1.71	0.85	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	27.17	1.69	6.41	0.84	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	35.44	1.27	3.40	0.42	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	0.00	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	25.48	2.51	2.51	0.72	0.72
medulla oblongata - adult, donor10196	10174-103C3	16.22	1.30	3.24	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	39.94	3.56	2.01	1.08	0.93
medulla oblongata, adult, pool1	10038-101F2	28.65	2.69	3.59	1.06	0.49
medulla oblongata, newborn, donor10223	10361-105F1	23.26	1.74	1.74	1.74	0.00
medulloblastoma cell line:D283 Med	10838-111E1	62.66	1.11	4.65	0.22	3.54
medulloblastoma cell line:ONS-76	10759-110E3	28.86	3.67	2.08	0.98	0.61
melanoma cell line:COLO 679	10514-107E1	27.89	4.02	3.02	1.44	0.72
melanoma cell line:G-361	10465-106H6	31.22	3.80	1.09	0.81	1.36
meningioma cell line:HKBMM	10691-109F7	41.97	5.97	4.88	0.36	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	72.25	2.64	2.64	0.88	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	79.32	1.04	3.11	2.33	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	30.99	2.76	3.53	0.92	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	24.54	7.09	3.82	1.82	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	27.74	1.66	2.07	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	18.54	0.42	3.79	0.56	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	22.92	2.12	3.66	0.58	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	23.60	1.39	3.47	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.80	7.38	3.60	0.69	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	26.11	2.76	1.96	0.58	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	30.90	1.72	2.25	1.46	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	32.54	3.24	2.30	1.35	1.22
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	23.76	2.42	2.56	1.56	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	23.71	6.59	3.62	1.65	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	28.23	3.32	2.63	1.38	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	25.83	1.75	2.44	2.09	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	18.99	2.04	3.47	0.82	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	25.52	3.59	2.52	1.44	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	21.41	1.66	2.69	0.21	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	16.19	2.96	3.19	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	28.11	2.10	2.94	2.52	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	26.15	1.20	2.09	1.49	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.12	5.86	5.08	0.70	1.23
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	29.82	8.47	4.05	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	24.04	1.14	3.72	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	41.68	4.21	2.95	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	21.46	0.91	1.37	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	22.00	1.28	1.28	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	27.75	4.19	1.05	1.05	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	25.88	2.77	1.23	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	22.59	1.41	1.18	1.18	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	27.08	2.03	1.35	1.02	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	23.97	0.79	1.18	0.39	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.46	2.32	1.85	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.69	1.15	2.31	1.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	23.87	1.34	1.78	0.00	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	23.79	1.92	3.12	0.48	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	25.67	1.47	1.47	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	29.20	2.35	3.02	2.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	22.93	1.64	2.46	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	22.77	1.72	3.44	2.15	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	2.73	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	21.76	1.30	1.62	0.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	14.55	1.45	0.00	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.12	3.20	2.67	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.90	1.64	1.64	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.21	1.17	2.33	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	23.84	1.99	2.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	4.77	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	18.38	1.78	3.56	2.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	2.44	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.67	1.90	1.90	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	22.42	2.41	2.07	1.03	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	49.43	4.30	0.00	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	3.44	0.00	0.00	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	29.75	1.22	3.26	0.81	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	29.39	1.59	1.59	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	27.71	1.18	2.36	0.59	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	25.87	1.56	2.81	0.62	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	26.73	0.00	2.67	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	35.48	5.91	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	30.98	2.07	0.00	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	24.74	0.99	1.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	0.00	3.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	3.18	3.18	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.37	2.42	4.03	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	2.18	6.54	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	12.67	1.27	6.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	16.39	5.46	2.43	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	18.08	9.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.00	11.53	2.47	0.00	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	28.97	1.98	3.17	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.15	2.27	0.65	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	18.34	1.02	3.06	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	11.61	0.77	3.09	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	32.13	2.83	1.18	1.18	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	30.58	11.35	3.94	1.16	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	15.72	4.11	1.85	0.72	0.21
mesothelioma cell line:Mero-25	10850-111F4	44.48	9.99	2.95	1.36	0.45
mesothelioma cell line:Mero-41	10851-111F5	64.79	8.80	4.40	2.44	0.49
mesothelioma cell line:Mero-48a	10852-111F6	34.32	5.54	2.66	1.55	0.22
mesothelioma cell line:Mero-82	10853-111F7	40.47	5.26	3.42	1.58	0.26
mesothelioma cell line:Mero-83	10854-111F8	37.62	3.40	3.40	1.70	0.85
mesothelioma cell line:Mero-84	10855-111F9	34.63	3.79	3.54	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	38.51	6.42	4.55	1.24	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	20.87	5.30	1.99	0.83	0.83
mesothelioma cell line:NCI-H226	10846-111E9	30.04	7.96	2.17	2.17	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	46.98	4.44	3.59	1.54	1.02
mesothelioma cell line:NCI-H28	10845-111E8	37.15	4.33	3.82	3.05	1.78
mesothelioma cell line:No36	10857-111G2	72.42	8.48	4.89	3.59	1.30
mesothelioma cell line:ONE58	10858-111G3	44.71	8.94	3.79	2.98	0.00
migratory langerhans cells, donor1	11901-125F2	11.52	0.77	2.30	0.96	0.38
migratory langerhans cells, donor2	11902-125F3	22.71	2.56	4.03	0.24	0.61
migratory langerhans cells, donor3	11903-125F4	23.69	1.79	2.51	2.15	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	54.52	3.92	1.63	0.98	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	41.96	4.24	1.48	1.06	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	20.73	4.15	5.30	0.92	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	32.35	0.76	2.66	1.52	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	118.64	12.38	5.36	4.99	1.29
myeloma cell line:PCM6	10474-106I6	61.28	6.72	11.46	3.16	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	7.10	1.01	2.03	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	20.59	3.73	1.96	0.98	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	24.74	2.79	2.34	0.45	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	24.56	4.27	2.43	0.59	0.88
nasal epithelial cells, donor2	12227-129F4	19.32	4.97	3.31	1.66	1.10
neuroblastoma cell line:CHP-134	10508-107D4	73.16	3.68	2.07	1.38	2.53
neuroblastoma cell line:NB-1	10539-107G8	72.03	6.36	6.74	3.37	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	57.36	1.27	2.53	1.05	0.63
neuroblastoma cell line:NH-12	10555-107I6	73.05	3.91	3.17	1.30	4.85
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	41.75	0.71	0.95	0.24	3.08
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	42.29	1.11	2.06	0.79	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	75.07	6.44	1.41	0.81	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	11.44	0.64	1.91	0.00	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	19.43	2.40	1.06	0.53	0.53
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	92.96	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	18.94	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	132.59	3.21	4.74	1.86	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	48.03	1.60	9.61	0.80	4.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	28.53	4.17	1.92	1.28	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	29.96	4.20	4.73	1.05	1.05
nucleus accumbens, adult, pool1	10037-101F1	31.12	1.59	5.34	1.41	0.37
occipital cortex - adult, donor10196	10172-103C1	35.03	2.06	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	35.69	2.15	1.07	0.81	0.81
occipital cortex, newborn, donor10223	10355-105E4	26.57	2.18	2.55	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	27.55	2.10	1.05	0.79	0.52
occipital lobe, fetal, donor1	10073-102A1	78.53	2.15	2.57	1.29	10.73
occipital pole, adult, pool1	10036-101E9	27.99	1.18	3.07	1.10	0.63
olfactory region, adult	10195-103E6	24.45	1.53	4.78	0.57	1.34
optic nerve, donor1	10277-104E7	16.01	0.00	0.00	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	48.18	13.33	5.58	2.85	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	42.04	2.20	1.24	0.41	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	24.55	3.73	4.91	0.68	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	17.21	2.54	2.08	0.35	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	19.11	1.18	2.06	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	32.70	2.80	6.54	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	76.34	13.57	5.09	2.12	0.85
ovary, adult, pool1	10020-101D2	30.84	2.62	2.01	0.87	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	29.51	1.65	2.02	1.65	1.10
pancreas, adult, donor1	10049-101G4	65.84	24.46	5.64	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	45.56	3.63	1.40	1.40	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	38.33	7.67	3.07	2.56	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	29.31	2.32	2.98	0.99	0.50
paracentral gyrus, adult, pool1	10035-101E8	29.01	1.28	3.57	0.82	0.73
parietal cortex, adult, donor10258	10373-105G4	15.41	0.73	1.47	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	30.10	0.94	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	33.92	1.14	3.14	0.86	0.57
parietal lobe, adult, pool1	10034-101E7	28.73	1.41	3.26	1.59	0.62
parietal lobe, fetal, donor1	10072-101I9	75.65	0.97	0.97	1.94	3.88
parietal lobe, newborn, donor10223	10356-105E5	21.31	2.24	1.87	0.75	0.75
parotid gland, adult	10199-103F1	51.18	18.50	3.70	3.08	0.62
penis, adult	10200-103F2	21.48	0.54	1.07	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	19.71	1.49	1.86	0.19	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	40.50	5.25	5.83	0.29	1.31
pineal gland - adult, donor10196	10179-103C8	16.13	1.29	3.87	0.65	1.29
pineal gland, adult, donor10252	10160-103A7	37.90	3.55	5.92	0.59	1.18
pineal gland, adult, donor10258	10377-105G8	18.19	0.00	2.51	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	69.81	3.04	11.13	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	78.70	3.65	13.03	1.56	1.04
pituitary gland, adult, donor10258	10378-105G9	57.03	5.96	8.51	2.55	0.85
placenta, adult, pool1	10021-101D3	27.74	1.51	2.47	0.54	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	37.48	2.65	3.58	0.40	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	21.79	3.89	1.25	1.25	0.47
pons, adult, pool1	10033-101E6	25.82	2.41	2.67	1.03	0.52
postcentral gyrus, adult, pool1	10032-101E5	33.39	1.74	3.66	0.96	0.87
promyelocytes/myelocytes PMC, donor1	12132-128D8	46.01	18.82	4.18	4.18	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	77.11	16.52	0.00	33.05	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	46.94	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	61.32	3.35	3.20	1.46	1.02
prostate cancer cell line:PC-3	10439-106E7	54.45	5.45	2.18	1.27	1.09
prostate, adult, pool1	10022-101D4	28.48	1.81	2.27	1.18	0.82
putamen, adult, donor10196	10176-103C5	30.22	0.71	3.78	0.47	1.89
putamen, adult, donor10252	10152-102I8	23.53	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	27.32	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	16.67	1.69	1.69	0.24	0.24
putamen, newborn, donor10223	10365-105F5	12.74	0.00	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	31.42	7.27	2.91	2.04	0.87
rectum, fetal, donor1	10067-101I4	41.73	4.17	1.39	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	21.20	0.64	1.48	1.06	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	44.73	3.73	0.00	0.41	2.07
retina, adult, pool1	10030-101E3	30.32	2.88	2.88	1.29	0.40
retinoblastoma cell line:Y79	10475-106I7	82.88	3.12	3.38	2.60	2.86
rhabdomyosarcoma cell line:KYM-1	10787-110H4	39.10	2.95	0.74	1.11	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	57.08	1.41	1.97	0.28	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.13	2.27	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	26.71	0.97	1.78	0.65	0.49
salivary acinar cells, donor2	11772-123I8	26.85	0.96	3.58	0.41	0.96
salivary acinar cells, donor3	11773-123I9	13.24	0.00	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	44.04	4.00	5.72	1.14	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	37.77	4.81	3.12	2.36	1.01
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	33.27	6.00	4.11	1.53	1.18
seminal vesicle, adult	10201-103F3	69.31	13.76	8.47	2.12	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	38.63	8.26	4.13	0.73	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	19.63	1.26	2.77	0.75	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	35.12	2.01	0.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	41.24	3.63	4.16	0.94	1.48
signet ring carcinoma cell line:Kato III	10436-106E4	33.16	6.41	2.10	2.32	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	23.48	4.77	4.39	2.45	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	7.09	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	13.31	1.80	1.20	0.60	0.48
skeletal muscle, fetal, donor1	10066-101I3	36.18	2.01	2.01	1.01	2.01
skin, adult, donor1	10074-102A2	27.14	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	58.70	1.89	0.63	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	44.69	2.33	4.67	1.33	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	69.03	9.14	5.36	1.89	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	66.50	3.66	8.67	1.16	3.66
small cell lung carcinoma cell line:LK-2	10541-107H1	37.58	1.65	5.44	0.82	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	65.79	1.93	2.25	0.16	4.18
small cell lung carcinoma cell line:WA-hT	10562-108A4	64.50	10.46	10.46	3.27	1.09
small intestine, adult, pool1	10024-101D6	19.95	9.79	2.99	1.79	0.24
small intestine, fetal, donor1	10064-101I1	23.59	8.85	3.44	0.98	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	63.09	21.03	7.18	6.67	0.00
smooth muscle, adult, pool1	10048-101G3	26.10	1.03	1.81	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	56.02	23.59	15.81	2.68	2.68
spinal cord - adult, donor10196	10181-103D1	20.19	1.61	0.92	1.38	0.46
spinal cord, adult, donor10252	10159-103A6	35.09	2.37	1.97	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	16.60	2.08	0.69	2.08	0.69
spinal cord, fetal, donor1	10056-101H2	42.69	4.27	2.44	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	23.88	2.30	2.76	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	17.03	2.54	0.75	0.00	0.60
spleen, adult, pool1	10025-101D7	36.67	3.19	4.19	1.76	0.22
spleen, fetal, pool1	10044-101F8	50.61	4.37	4.53	1.11	0.56
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	27.74	2.07	2.28	0.52	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	26.96	2.85	4.56	0.76	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	43.68	6.29	5.24	1.05	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	41.05	8.60	7.82	1.17	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	58.53	12.94	8.55	3.60	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	78.37	3.39	4.24	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	42.73	7.19	2.12	0.42	1.27
stomach, fetal, donor1	10062-101H8	20.29	2.14	3.20	1.07	0.00
submaxillary gland, adult	10202-103F4	56.40	9.68	6.27	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	51.10	2.91	1.45	1.45	0.62
substantia nigra, adult, donor10258	10371-105G2	15.00	1.03	1.55	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	18.37	2.12	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	84.60	2.98	3.67	1.38	2.06
temporal lobe, adult, pool1	10031-101E4	37.13	2.12	3.73	1.53	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	89.75	2.14	1.42	0.71	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	76.48	0.00	7.47	0.88	4.40
tenocyte, donor1	11763-123H8	39.10	2.44	2.09	0.70	0.70
tenocyte, donor2	11765-123I1	24.42	1.14	4.20	0.38	0.38
tenocyte, donor3	11768-123I4	31.88	1.85	1.85	1.11	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	37.39	1.87	2.38	1.70	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	43.62	2.16	1.39	0.31	1.39
teratocarcinoma cell line:PA-1	10807-111A6	42.15	2.01	1.24	0.46	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	55.22	14.60	4.44	3.05	1.52
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	34.41	2.65	1.51	0.00	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	40.13	6.43	7.85	1.42	4.80
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	27.68	1.95	1.95	0.98	1.30
testis, adult, pool1	10026-101D8	26.74	2.68	2.36	0.75	0.64
testis, adult, pool2	10096-102C6	41.95	1.80	4.96	0.00	0.45
thalamus - adult, donor10196	10168-103B6	16.56	0.00	2.21	1.10	0.00
thalamus, adult, donor10252	10154-103A1	39.07	2.81	2.50	0.63	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	16.94	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	17.95	2.47	1.32	0.82	0.99
thalamus, newborn, donor10223	10366-105F6	16.11	1.73	0.00	0.58	0.00
throat, adult	10209-103G2	28.96	1.50	1.50	1.00	0.50
throat, fetal, donor1	10061-101H7	33.82	3.35	4.57	0.00	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	60.02	0.79	4.37	0.60	1.19
thymus, adult, pool1	10027-101D9	54.78	1.99	5.77	0.70	1.09
thymus, fetal, pool1	10043-101F7	51.74	1.56	6.13	0.42	1.35
thyroid carcinoma cell line:KHM-5M	10776-110G2	47.73	10.77	3.86	2.79	1.46
thyroid carcinoma cell line:TCO-1	10783-110G9	46.52	12.43	3.49	1.54	0.70
thyroid, adult, pool1	10028-101E1	42.74	4.39	2.61	0.93	1.21
thyroid, fetal, donor1	10060-101H6	43.24	3.69	3.69	1.32	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	20.70	2.33	2.33	0.93	0.23
tongue, fetal, donor1	10059-101H5	21.28	1.97	2.76	0.39	1.58
tonsil, adult, pool1	10047-101G2	42.17	3.81	6.11	1.10	1.10
trachea, adult, pool1	10029-101E2	31.49	4.42	3.60	1.39	0.57
trachea, fetal, donor1	10058-101H4	33.08	2.31	2.69	1.54	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.03	2.83	1.77	1.42	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	34.95	10.13	1.52	2.23	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	53.90	12.69	3.92	1.88	1.25
tridermal teratoma cell line:HGRT	10694-109G1	3.81	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	36.82	7.20	4.57	0.76	0.51
umbilical cord, fetal, donor1	10057-101H3	33.38	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	44.02	4.78	2.90	1.37	0.17
uterus, fetal, donor1	10055-101H1	44.54	1.54	2.56	0.00	1.54
vagina, adult	10204-103F6	34.25	1.29	1.29	0.65	0.65
vein, adult	10191-103E2	37.48	1.10	4.82	0.88	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	30.44	2.67	4.81	1.07	0.00